With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Jabil Inc., a provider of engineering, manufacturing, and supply chain solutions, has acquired Pharmaceutics International ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii) to offer ...

Jabil's diversification in end markets, particularly Auto & Transportation and Healthcare & Packaging, is driving revenue ...

SG Americas Securities LLC reduced its holdings in Jabil Inc. (NYSE:JBL – Free Report) by 70.7% during the fourth quarter, ...

Jabil (JBL) announced the acquisition of Pharmaceutics International, completed February 3. “Jabil is very pleased to ...

The electronics multinational Jabil has decided to initiate the sale of its business, with the Marcianise plant and its 413 ...

A Hunt Valley drug manufacturing company with more than 300 employees has been acquired by a Fortune 500 firm.

Jabil (JBL) closed the most recent trading day at $163.62, moving +1.11% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.39%. Meanwhile, the Dow experienced a rise ...

An investor group led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc have sold their equity stake in Pharmaceutics International, Inc, a Hunt Valley, ...

Global manufacturer Jabil plans to hire hundreds of new workers at a Northern Kentucky facility. STORY HIGHLIGHTS Jabil plans ...